Top Stories
PrecivityAD2 is the first authorised blood test in the US for adults as young as 40 with cognitive symptoms.
Aletta handles most of the blood-draw procedure itself, starting with finding a vein to changing tubes and finishing by placing a bandage.
The startup already has a $30-million-plus co-development and licensing deal with a Fortune 100 healthcare company and is working with NVIDIA to scale its medical AI models.
ENV-308 was designed to mimic the appetite-suppressing effect of a natural hormone released post-exercise, called Lac-Phe.
The agency is seeking input from the public on risk assessment, premarket evaluation and postmarket monitoring for the "transformative" devices.
Conference News
Neuroscience 2026, the annual meeting of the Society for Neuroscience, will be held November 14–18, 2026 in Washington, DCPresentation Title: Assessing Treatment-Associated Brain Network Changes Foll...
COPENHAGEN, Denmark, August 20, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, provides business...
Results characterized by continued strong commercial momentum and improved operating performanceConference call/webcast today at 5:00 pm ETTORONTO and DALLAS, Aug. 20, 2026 /PRNewswire/ -- Perimeter M...
Real-world evidence on NSCLC treatment patterns and outcomes showcases Flatiron's unified, global oncology engineNEW YORK--(BUSINESS WIRE)-- Flatiron Health today announced its presence at the IASLC 2...
DALLAS, Aug. 18, 2026 — Despite rapid advances in digital health, artificial intelligence and remote patient monitoring, many promising health technologies still fail to reach patients who need them m...
